Together, these solid findings demonstrate that Nrg4 serves as an immune checkpoint involved in the crosstalk of the pro-oncogenic microenvironment in NASH and can protect against HCC through profound immune reprogramming (Figure 4). The gene discussed is NRG4; the disease is hepatocellular carcinoma.